These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31385518)

  • 1. A novel prognostic marker based on risk stratification with prognostic nutritional index and age for nasopharyngeal carcinoma patients who received neoadjuvant chemotherapy.
    He Q; Huang Y; Wan G; Feng M; Zeng H; Liu M; Luo H; Yang Y; Song X; Zhang L; Lang J
    Biomark Med; 2019 Aug; 13(12):1013-1023. PubMed ID: 31385518
    [No Abstract]   [Full Text] [Related]  

  • 2. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
    Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
    Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in local-regionally advanced nasopharyngeal carcinoma: A National Cancer Database analysis.
    Tam M; Lee A; Wu SP; Gerber NK; Li Z; Givi B; Hu K; Schreiber D
    Laryngoscope; 2018 Dec; 128(12):2770-2777. PubMed ID: 30133799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
    Majidova N; Sarı M; Kahvecioglu FA; Ozcan E; Akdag MO; Dogan A; Yıldırım S; Sonusen SD; Yunusov E; Yasar A; Celebi A; Sever N; Kocaaslan E; Erel P; Agyol Y; Guren AK; Arıkan R; Isık S; Balvan O; Geredelı C; Uygun K; Hacibekiroglu I; Kostek O; Bayoglu IV
    Oncol Res Treat; 2024; 47(7-8):360-367. PubMed ID: 38565096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Five-Year Survival Rate of Patients with Nasopharyngeal Carcinoma Based on Tumor Response after Receiving Neoadjuvant Chemotherapy, Followed by Chemoradiation, in Indonesia: A Retrospective Study.
    Dwijayanti F; Prabawa A; Besral ; Herawati C
    Oncology; 2020; 98(3):154-160. PubMed ID: 31995803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
    Duan YY; Deng J; Su DF; Li WQ; Han Y; Li ZX; Huan XZ; Zhu SH; Yang QL; Hu W; Xin MZ; Tang LQ; Mai HQ; Fan YY; He Y
    Support Care Cancer; 2021 Sep; 29(9):5371-5381. PubMed ID: 33686519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the tumor volume reduction rate after neoadjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma.
    Yang H; Liu Y; Zhang R; Ye Y; Chen Q; Qin Q; Huang L; Li X; Cai R; Tang H; Jiang W
    Oral Oncol; 2020 Nov; 110():104897. PubMed ID: 32679404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Wu JS; Tsai YC; Jian JJ; Chen HH; Horng CF; Cheng SH
    Head Neck; 2018 Sep; 40(9):2070-2077. PubMed ID: 29756398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients.
    Xiong Y; Shi LL; Zhu LS; Peng G
    Ann Palliat Med; 2021 Apr; 10(4):4122-4133. PubMed ID: 33832314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
    Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment low prognostic nutritional index and low albumin-globulin ratio are predictive for overall survival in nasopharyngeal cancer.
    Gundog M; Basaran H
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3221-3230. PubMed ID: 31401760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma.
    Küçükarda A; Erdoğan B; Gökyer A; Sayın S; Gökmen İ; Özcan E; Hacıoğlu MB; Uzunoğlu S; Çiçin İ
    Support Care Cancer; 2022 Mar; 30(3):2131-2139. PubMed ID: 34677649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
    Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma.
    Zong J; Xu H; Chen B; Guo Q; Xu Y; Chen C; Weng Y; Zheng W; Pan J; Lin S
    Radiat Oncol; 2019 Oct; 14(1):182. PubMed ID: 31640719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Nasopharyngeal Carcinoma: A Rare Tumor in a Developing Country-What Do We Learn?
    Zekri W; Wahed MA; Attia E; Khalil E
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):e140-e146. PubMed ID: 31789781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic nutritional index and serum lactate dehydrogenase predict the prognosis of nasopharyngeal carcinoma patients who received intensity-modulated radiation therapy.
    Zhang C; Zhan Z; Fang Y; Ruan Y; Lin M; Dai Z; Zhang Y; Yang S; Xiao S; Chen B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17795-17805. PubMed ID: 37934254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.